共 79 条
[1]
Lampertico P(2017)EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection J Hepatol 67 370-398
[2]
Agarwal K(2006)Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 65-73
[3]
Berg T(2014)HBsAg quantification for identification of liver disease in chronic hepatitis B virus carriers Liver Int 34 e238-e245
[4]
Buti M(2010)Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers Hepatology 51 1933-1944
[5]
HLA J(2017)The role of quantitative hepatitis B surface antigen revisited J Hepatol 66 398-411
[6]
Papatheodoridis G(2015)Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors Hepatology 61 66-76
[7]
Chen C-J(2015)Hepatitis B virus Pregenomic RNA is present in Virions in plasma and is associated with a response to Pegylated interferon alfa-2a and Nucleos(t)ide analogues J Infect Dis 213 224-232
[8]
Yang H-I(2001)Hepatitis B virus nucleic acids circulating in the blood: distinct patterns in HBs carriers with hepatocellular carcinoma Ann N Y Acad Sci 945 195-206
[9]
Su J(2006)Hepatitis B virus RNA is measurable in serum and can be a new marker for monitoring lamivudine therapy J Gastroenterol Springer-Verlag 41 785-790
[10]
Jen C-L(2000)Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B J Viral Hepat 7 258-267